These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 24834885

  • 21. Hepatoma feeding arteriogram created by CT during aortography using IVR 64-multidetector-row CT for catheterization in transcatheter arterial chemoembolization for hepatocellular carcinoma.
    Minamiguchi H, Kawai N, Sato M, Ikoma A, Sanda H, Nakata K, Tanaka F, Nakai M, Sonomura T, Murotani K, Hosokawa S, Nishioku T.
    Jpn J Radiol; 2013 Jun; 31(6):428-36. PubMed ID: 23657922
    [Abstract] [Full Text] [Related]

  • 22. Use of contrast-enhanced ultrasonography with a perflubutane-based contrast agent performed one day after transarterial chemoembolization for the early assessment of residual viable hepatocellular carcinoma.
    Takizawa K, Numata K, Morimoto M, Kondo M, Nozaki A, Moriya S, Ishii T, Oshima T, Fukuda H, Okada M, Takebayashi S, Maeda S, Tanaka K.
    Eur J Radiol; 2013 Sep; 82(9):1471-80. PubMed ID: 23769188
    [Abstract] [Full Text] [Related]

  • 23. Identification of the feeding arteries of hepatocellular carcinomas by performing dual arterial phase CT during pre-transarterial chemoembolization angiography.
    Ohta K, Shimohira M, Hashizume T, Suzuki K, Sawada Y, Shibamoto Y.
    Abdom Radiol (NY); 2019 Jun; 44(6):2276-2282. PubMed ID: 30788560
    [Abstract] [Full Text] [Related]

  • 24. Dual-phase Cone-beam CT-based Navigation Imaging Significantly Enhances Tumor Detectability and Aids Superselective Transarterial Chemoembolization of Liver Cancer.
    Yao X, Yan D, Jiang X, Li X, Zeng H, Liu D, Li H.
    Acad Radiol; 2018 Aug; 25(8):1031-1037. PubMed ID: 29398432
    [Abstract] [Full Text] [Related]

  • 25. Quantitative evaluation of CT-perfusion map as indicator of tumor response to transarterial chemoembolization and radiofrequency ablation in HCC patients.
    Ippolito D, Fior D, Bonaffini PA, Capraro C, Leni D, Corso R, Sironi S.
    Eur J Radiol; 2014 Sep; 83(9):1665-71. PubMed ID: 24962900
    [Abstract] [Full Text] [Related]

  • 26. Hepatocellular carcinoma: assessment of response to transarterial chemoembolization with image subtraction.
    Kim S, Mannelli L, Hajdu CH, Babb JS, Clark TW, Hecht EM, Taouli B.
    J Magn Reson Imaging; 2010 Feb; 31(2):348-55. PubMed ID: 20099348
    [Abstract] [Full Text] [Related]

  • 27. Origins of feeding arteries of hepatocellular carcinoma located near the umbilical fissure of the left hepatic lobe: angiographic evaluation.
    Miyayama S, Yamashiro M, Shibata Y, Hashimoto M, Yoshida M, Tsuji K, Toshima F, Matsui O.
    Cardiovasc Intervent Radiol; 2012 Dec; 35(6):1380-7. PubMed ID: 22173641
    [Abstract] [Full Text] [Related]

  • 28. Parenchymal Liver Blood Volume and Dynamic Volume Perfusion CT Measurements of Hepatocellular Carcinoma in Patients Undergoing Transarterial Chemoembolization.
    Rathmann N, Kara K, Budjan J, Henzler T, Smakic A, Schoenberg SO, Diehl SJ.
    Anticancer Res; 2017 Oct; 37(10):5681-5685. PubMed ID: 28982886
    [Abstract] [Full Text] [Related]

  • 29. Computed tomography perfusion in evaluating the therapeutic effect of transarterial chemoembolization for hepatocellular carcinoma.
    Chen G, Ma DQ, He W, Zhang BF, Zhao LQ.
    World J Gastroenterol; 2008 Oct 07; 14(37):5738-43. PubMed ID: 18837093
    [Abstract] [Full Text] [Related]

  • 30. The usefulness of contrast-enhanced ultrasonography in the early detection of hepatocellular carcinoma viability after transarterial chemoembolization: pilot study.
    Cho YZ, Park SY, Choi EH, Baik SK, Kwon SO, Kim YJ, Cha SH, Kim MY.
    Clin Mol Hepatol; 2015 Jun 07; 21(2):165-74. PubMed ID: 26157754
    [Abstract] [Full Text] [Related]

  • 31. Application of gemstone spectral imaging for efficacy evaluation in hepatocellular carcinoma after transarterial chemoembolization.
    Liu QY, He CD, Zhou Y, Huang D, Lin H, Wang Z, Wang D, Wang JQ, Liao LP.
    World J Gastroenterol; 2016 Mar 21; 22(11):3242-51. PubMed ID: 27004002
    [Abstract] [Full Text] [Related]

  • 32. Optimized Performance of FlightPlan during Chemoembolization for Hepatocellular Carcinoma: Importance of the Proportion of Segmented Tumor Area.
    Joo SM, Kim YP, Yum TJ, Eun NL, Lee D, Lee KH.
    Korean J Radiol; 2016 Mar 21; 17(5):771-8. PubMed ID: 27587967
    [Abstract] [Full Text] [Related]

  • 33. Prediction of Embolization Area after Conventional Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma Using SYNAPSE VINCENT.
    Ogawa C, Minami Y, Morita M, Noda T, Arasawa S, Izuta M, Kubo A, Matsunaka T, Tamaki H, Shibatoge M, Kudo M.
    Dig Dis; 2016 Mar 21; 34(6):696-701. PubMed ID: 27750240
    [Abstract] [Full Text] [Related]

  • 34. Image quality of arterial phase and parenchymal blood volume (PBV) maps derived from C-arm computed tomography in the evaluation of transarterial chemoembolization.
    Zitzelsberger T, Syha R, Grözinger G, Partovi S, Nikolaou K, Grosse U.
    Cancer Imaging; 2018 May 02; 18(1):16. PubMed ID: 29720249
    [Abstract] [Full Text] [Related]

  • 35. Hepatocellular carcinoma in the caudate lobe of the liver: angiographic analysis of tumor-feeding arteries according to subsegmental location.
    Yoon CJ, Chung JW, Cho BH, Jae HJ, Kang SG, Kim HC, Choi YH, Jeon UB, Park JH.
    J Vasc Interv Radiol; 2008 Nov 02; 19(11):1543-50; quiz 1550. PubMed ID: 18755606
    [Abstract] [Full Text] [Related]

  • 36. Quantification of perfusion reduction by using 2D-perfusion angiography following transarterial chemoembolization with drug-eluting beads.
    Maschke SK, Werncke T, Klöckner R, Rodt T, Renne J, Kirstein MM, Vogel A, Wacker FK, Meyer BC, Hinrichs JB.
    Abdom Radiol (NY); 2018 May 02; 43(5):1245-1253. PubMed ID: 28840307
    [Abstract] [Full Text] [Related]

  • 37. Evaluation of the microcirculation of hepatocellular carcinomas using contrast-enhanced ultrasound with intraarterial and intravenous contrast application during transarterial chemoembolization with drug-eluting beads (DEB-TACE): preliminary data.
    Uller W, Wiggermann P, Gössmann H, Klebl F, Salzberger B, Stroszczynski C, Jung EM.
    Clin Hemorheol Microcirc; 2011 May 02; 49(1-4):55-66. PubMed ID: 22214678
    [Abstract] [Full Text] [Related]

  • 38. The Role of Cone-Beam CT in Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma: A Systematic Review and Meta-analysis.
    Pung L, Ahmad M, Mueller K, Rosenberg J, Stave C, Hwang GL, Shah R, Kothary N.
    J Vasc Interv Radiol; 2017 Mar 02; 28(3):334-341. PubMed ID: 28109724
    [Abstract] [Full Text] [Related]

  • 39. Role of C-arm CT for transcatheter arterial chemoembolization of hepatocellular carcinoma: diagnostic performance and predictive value for therapeutic response compared with gadoxetic acid-enhanced MRI.
    Yu MH, Kim JH, Yoon JH, Kim HC, Chung JW, Han JK, Choi BI.
    AJR Am J Roentgenol; 2013 Sep 02; 201(3):675-83. PubMed ID: 23971463
    [Abstract] [Full Text] [Related]

  • 40. Chemoembolization of the left inferior phrenic artery in patients with hepatocellular carcinoma: 9-year single-center experience.
    Kim HC, Chung JW, Kim WH, An S, Seong NJ, Jae HJ, Park JH.
    AJR Am J Roentgenol; 2010 Apr 02; 194(4):1124-30. PubMed ID: 20308521
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.